Methods for inhibiting cell proliferation

Details Methods for inhibiting cell proliferation Methods for inhibiting cell proliferation

2001-04-26

2011-10-04

Bristol, Lynn (Department: 1643)

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Monoclonal antibody or fragment thereof

Reexamination Certificate

active

08029793

ABSTRACT:
Provided are proliferation inhibitors for cells whose proliferation is stimulated by PTHrP (34-53), comprising a substance inhibiting the binding of PTHrP (1-34) to its receptor.

REFERENCES:
patent: 4771124 (1988-09-01), Rosenblatt et al.
patent: 5001223 (1991-03-01), Rosenblatt et al.
patent: 5217896 (1993-06-01), Kramer et al.
patent: 5626845 (1997-05-01), Yoneda et al.
patent: 5849695 (1998-12-01), Cohen et al.
patent: 5993817 (1999-11-01), Yoneda et al.
patent: 6903194 (2005-06-01), Sato et al.
patent: 2005/0244414 (2005-11-01), Mundy et al.
patent: 0 293 130 (1988-11-01), None
patent: 0 293 158 (1988-11-01), None
patent: 0 449 405 (1991-10-01), None
patent: 0 811 383 (1997-12-01), None
patent: 0 878 201 (1998-11-01), None
patent: 0 962 467 (1999-12-01), None
patent: 1 004 313 (2000-05-01), None
patent: 1 090 643 (2001-04-01), None
patent: 0 813 423 (2002-07-01), None
patent: 2-207099 (1990-08-01), None
patent: 4-502408 (1992-05-01), None
patent: 04228089 (1992-08-01), None
patent: 7-165790 (1995-06-01), None
patent: 7-316195 (1995-12-01), None
patent: 11-80025 (1999-03-01), None
patent: 11-222440 (1999-08-01), None
patent: 2000-080100 (2000-03-01), None
patent: WO 89/11297 (1989-11-01), None
patent: WO 89/11298 (1989-11-01), None
patent: WO 90/07861 (1990-07-01), None
patent: WO 91/16928 (1991-11-01), None
patent: WO 92/00753 (1992-01-01), None
patent: WO 92/17602 (1992-10-01), None
patent: WO 92/19759 (1992-11-01), None
patent: WO 93/13133 (1993-07-01), None
patent: WO 94/11523 (1994-05-01), None
patent: WO 96/03437 (1996-02-01), None
patent: WO 96/39184 (1996-02-01), None
patent: WO 96/22790 (1996-08-01), None
patent: WO 96/26737 (1996-09-01), None
patent: WO 96/33735 (1996-10-01), None
patent: WO 98/13388 (1998-04-01), None
patent: WO 98/51329 (1998-11-01), None
patent: WO 99/57139 (1999-11-01), None
patent: WO 00/00219 (2000-01-01), None
Nakashima et al (J. Pathol. 175:227-236 (1995)).
Guise et al. (J. Clin. Invest. 98(7):1544-1549 (1996)).
Cataisson et al. (J. Bone & Mineral Res. 15:2129-2139 (Nov. 11, 2000).
Kaiser, S.M., et al., (1992) J. Biol. Chem.; 267(19):13623-13628.
Fortier, A.H., et al., (1999) Journal of the National Cancer Institute; 91:1635-1640.
McGowan, E.M., et al., (1999) Molecular Endocrinology; 13:1657-1671.
Reichert et al. Nature Biotech. 23(9): 1073-1078 (2005).
Mayo Clinic.com “Monoclonal antibody drugs” pp. 1-5 (Jan. 2007).
Sato et al. Sem. Oncol. 30(5):167-73 (2003) (Abstract).
Onuma et al. (Anticancer Res. 24(5A): 2665-73 (2004) (Abstract).
Voskoglou-Nomikos (Clin. Can. Res. 9:4227-4239 (2003)).
Dennis (Nature 442:739-741 (2006)).
Cespdes et al. (Clin. Transl. Oncol. 8(5):318-329 (2006)).
Talmadge et al. (Am. J. Pathol 170(3):793-804 (2007)).
http//en.wikipedia.org/wiki/Monoclonal antibody therapy, pp. 1-6 (Aug. 3, 2009).
Fujimori et al. (J. Nuc. Med. 31:1191-1198 (1990)).
Beckman et al. (Can. 109:170-179 (2007).
Thurber et al. (Adv. Drug Deliv. Rev. 60:1421-1434 (2008).
Rudnick et al. (Can. Biotherp. & Radiopharm. 24: 155-162 (2009)).
Funk et al., 1999, “Expression of parathyroid hormone-related protein and the parathyroid hormone/parathyroid hormone-related protein receptor in rat thymic epithelial cells,” J. Anat., 194(2): 255-264.
Philbrick et al., 1996, “Defining the Roles of Parathyroid Hormone-Related Protein in Normal Physiology,” Physiological Reviews, 76(1): 127-173.
Sato et al., 1993, “Passive Immunization with Anti-Parathyroid Hormone-Related Protein Monoclonal Antibody Markedly Prolongs Survival Time of Hypercalcemic Nude Mice Bearing Transplanted Human PTHrP-Producing Tumors,” J. Bone Miner. Res., 8(7): 849-860.
International Search Report for PCT/JP01/03665, mailed Aug. 14, 2001.
U.S. Appl. No. 09/269,332, filed Mar. 25, 1999, Sato et al.
U.S. Appl. No. 10/337,981, filed Nov. 12, 1999, Sato et al.
U.S. Appl. No. 09/720,326, filed Dec. 22, 2000, Sato et al.
U.S. Appl. No. 10/019,501, filed Dec. 31, 2001, Ogata et al.
U.S. Appl. No. 10/019,571, filed Dec. 31, 2001, Ogata et al.
U.S. Appl. No. 10/019,785, filed Jan. 4, 2002, Saito et al.
U.S. Appl. No. 10/169,003, filed Jun. 26, 2002, Yamazaki et al.
U.S. Appl. No. 10/182,018, filed Jul. 24, 2002, Kato et al.
U.S. Appl. No. 10/229,149, filed Aug. 27, 2002, Saito et al.
Abou-Samra et al., Expression Cloning of a Common Receptor for Parathyroid Hormone and Parathyroid Hormone-Related Peptide from Rat Osteoblast-Like Cells: A Single Receptor Stimulates Intracellular Accumulation of Both cAMP and Inositol Trisphosphates and Increases Intracellular Free Calcium,Proceedings of the National Academy of Sciences, 89:2732-2736 (1992).
Baba, PTH/PTHrP,Clinical Calcium, 5:97-101 (1995) (English Translation).
Beck et al., Lipolytic Factors Associated with Murine and Human Cancer Cachexia,Journal of the National Cancer Institute, 82:1922-1926 (1990).
Belyavsky et al., PCR-Based cDNA Library Construction: General cDNA Libraries at the Level of a Few Cells,Nucleic Acids Research, 17:2919-2933 (1989).
Burtis, Parathyroid Hormone-Related Protein: Structure, Function, and Measurement,Clinical Chemistry, 38:2171-2183 (1992).
Carter et al., Humanization of an Anti-p185HER2Antibody for Human Cancer Therapy,Proceedings of the National Academy of Sciences, 89:4285-4289 (1992).
Chirgwin et al., Isolation of Biologically Active Ribonucleic Acid From Sources Enriched in Ribonuclease,Biochemistry, 18:5294-5299 (1979).
Chomczynski et al., Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate-Phenol-Chloroform Extraction,Analytical Biochemistry, 162:156-159 (1987).
Chothia, Canonical Structures for the Hypervariable Regions of Immunoglobulins,Journal of Molecular Biology, 196:901-917 (1987).
Co et al., Chimeric and Humanized Antibodies with Specificity for the CD33 Antigen,The Journal of Immunology, 148:1149-1154 (1992).
Co et al., Humanized Antibodies for Antiviral Therapy,Proceedings of the National Academy of Sciences, 88:2869-2873 (1991).
Coleman et al., Biochemical Mechanisms of Parathyroid Hormone Action,The Parathyroids, Basic and Clinical Concepts, 239-258 (1994).
Cuisinier et al., Mechanisms That Generate Human Immunoglobulin Diversity Operate From the 8thWeek of Gestation in Fetal Liver,European Journal of Immunology, 23:110-118 (1993).
Dariavach et al., Human Immunoglobulin Cλ6 Gene Encodes the Kern+Oz λ Chain and Cλ4 andCλ5 are Pseudogenes,Proceedings of the National Academy of Sciences, 84:9074-9078 (1987).
Deftos et al., Utilization of a Potentially Universal Downstream Primer in the Rapid Identification and Characterization of Vλ Genes From Two New Human Vλ Families,Scandinavian Journal of Immunology, 39:95-103 (1994).
de St. Groth et al., Production of Monoclonal Antibodies: Strategy and Tactics,Journal of Immunological Methods, 35:1-21 (1980).
Dworkin et al., Dietary Intake in Patients with Acquired Immunodeficiency Syndrome (AIDS), Patients with AIDS-Related Complex, and Serologically Positive Human Immunodeficiency Virus Patients: Correlations with Nutritional Status,Journal of Parenteral and Enteral Nutrition, 14:605-609 (1990).
Farmer et al., Speculations on the Design of Nonpeptidic Peptidomimetics,TIPS, 4:362-365, (1982).
Frohman et al., Rapid Production of Full-Length cDNAs From Rare Transcripts: Amplification Using a Single Gene-Specific Oligonucleotide Primer,Proceedings of the National Academy of Sciences, 85:8998-9002 (1988).
Galfrè et al., Rat × Rat Hybrid Myelomas and a Monoclonal Anti-Fd Portion of Mouse IgG,Nature, 277:131-133 (1979).
Gorman et al., Reshaping a Therapeutic CD4 Antibody,Proceedings of the National Academy of Sciences, 88:4181-4185 (1991).
Hammond et al., Respiratory Muscle Strength in Congestive Heart Failure,Chest, 98:1091-1094 (1990).
Hardman et al., Goodman & Gilman's, The Pharmacological Basis of Therapeutics,Hormones and Hormone Anatgonists, McGraw-Hill Co. (USA) 9thed., pp. 1528-1529 (1995).
Hardman et al., Goodman & Gilman's The Pharmacological Basis of Therapeutics,Hormones and Hormone Anatgonists, McGraw-Hill Co. (USA) 9

Affiliated with

Also associated with

Rating

Methods for inhibiting cell proliferation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for inhibiting cell proliferation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for inhibiting cell proliferation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4289645